EFFICIENT GENE-TRANSFER INTO NONDIVIDING CELLS BY ADENOASSOCIATED VIRUS-BASED VECTORS

被引:201
作者
PODSAKOFF, G
WONG, KK
CHATTERJEE, S
机构
[1] CITY HOPE NATL MED CTR,DEPT HEMATOL & BONE MARROW TRANSPLANTAT,DUARTE,CA 91010
[2] CITY HOPE NATL MED CTR,DIV PEDIAT,DUARTE,CA 91010
[3] CITY HOPE NATL MED CTR,BECKMAN RES INT,DUARTE,CA 91010
关键词
D O I
10.1128/JVI.68.9.5656-5666.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Gene transfer vectors based on adeno-associated virus (AAV) are emerging as highly promising for use in human gene therapy by virtue of their characteristics of wide host range, high transduction efficiencies, and lack of cytopathogenicity. To better define the biology of AAV-mediated gene transfer, we tested the ability of an AAV vector to efficiently introduce transgenes into nonproliferating cell populations. Cells were induced into a nonproliferative state by treatment with the DNA synthesis inhibitors fluorodeoxyuridine and aphidicolin or by contact inhibition induced by confluence and serum starvation. Cells in logarithmic growth or DNA synthesis arrest were transduced with vCWR:beta gal, an AAV-based vector encoding beta-galactosidase under Rous sarcoma virus long terminal repeat promoter control. Under each condition tested, vCWR:beta Gal expression in nondividing cells was at least equivalent to that in actively proliferating cells, suggesting that mechanisms for virus attachment, nuclear transport, virion uncoating, and perhaps some limited second-strand synthesis of AAV vectors were present in nondividing cells. Southern hybridization analysis of vector sequences from cells transduced while in DNA synthetic arrest and expanded after release of the block confirmed ultimate integration of the vector genome into cellular chromosomal DNA. These findings may provide the basis for the use of AAV-based vectors for gene transfer into quiescent cell populations such as totipotent hematopoietic stem cells.
引用
收藏
页码:5656 / 5666
页数:11
相关论文
共 56 条
[1]   HUMAN GENE-THERAPY [J].
ANDERSON, WF .
SCIENCE, 1992, 256 (5058) :808-813
[2]   ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES [J].
ATCHISON, RW ;
CASTO, BC ;
HAMMON, WM .
SCIENCE, 1965, 149 (3685) :754-&
[3]   EXPRESSION OF THE HUMAN BETA-GLOBIN GENE AFTER RETROVIRAL TRANSFER INTO MURINE ERYTHROLEUKEMIA-CELLS AND HUMAN BFU-E CELLS [J].
BENDER, MA ;
MILLER, AD ;
GELINAS, RE .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (04) :1725-1735
[4]   DETECTION OF ADENO-ASSOCIATED VIRUS (AAV)-SPECIFIC NUCLEOTIDE-SEQUENCES IN DNA ISOLATED FROM LATENTLY INFECTED DETROIT 6 CELLS [J].
BERNS, KI ;
PINKERTON, TC ;
THOMAS, GF ;
HOGGAN, MD .
VIROLOGY, 1975, 68 (02) :556-560
[5]   ADENOASSOCIATED VIRUSES - AN UPDATE [J].
BERNS, KI ;
BOHENZKY, RA .
ADVANCES IN VIRUS RESEARCH, 1987, 32 :243-306
[6]   DEVELOPMENT OF GENE-THERAPY FOR IMMUNODEFICIENCY - ADENOSINE-DEAMINASE DEFICIENCY [J].
BLAESE, RM .
PEDIATRIC RESEARCH, 1993, 33 (01) :S49-S55
[7]   RETROVIRAL VECTOR-MEDIATED HIGH-EFFICIENCY EXPRESSION OF ADENOSINE-DEAMINASE (ADA) IN HEMATOPOIETIC LONG-TERM CULTURES OF ADA-DEFICIENT MARROW-CELLS [J].
BORDIGNON, C ;
YU, SF ;
SMITH, CA ;
HANTZOPOULOS, P ;
UNGERS, GE ;
KEEVER, CA ;
OREILLY, RJ ;
GILBOA, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6748-6752
[8]   GENE-MARKING TO TRACE ORIGIN OF RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
BRENNER, MK ;
RILL, DR ;
MOEN, RC ;
KRANCE, RA ;
MIRRO, J ;
ANDERSON, WF ;
IHLE, JN .
LANCET, 1993, 341 (8837) :85-86
[9]   HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2 COMPLETELY HELP ADENOVIRUS-ASSOCIATED VIRUS-REPLICATION [J].
BULLER, RML ;
JANIK, JE ;
SEBRING, ED ;
ROSE, JA .
JOURNAL OF VIROLOGY, 1981, 40 (01) :241-247
[10]   DUAL-TARGET INHIBITION OF HIV-1 INVITRO BY MEANS OF AN ADENOASSOCIATED VIRUS ANTISENSE VECTOR [J].
CHATTERJEE, S ;
JOHNSON, PR ;
WONG, KK .
SCIENCE, 1992, 258 (5087) :1485-1488